Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 15Terminated 4Recruiting 4Not yet recruiting 3Withdrawn 2Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Gynecologic 3Head & Neck 2Genitourinary 2Thoracic 1Plasma cell 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 38Azacitidine 24fludarabine 20Cytarabine 18Cyclophosphamide 16Specimen Handling 14blinatumomab 13Biopsy 12Busulfan 8Dexamethasone 7Melphalan 6Daunorubicin 6Whole-Body Irradiation 5Vincristine 5Thiotepa 5Methotrexate 5Decitabine 5gilteritinib 4daratumumab 4Tacrolimus 4Stem Cell Transplantation 4Magnetic Resonance Spectroscopy 4Imatinib Mesylate 4Idarubicin 4Exercise 4Blood Specimen Collection 4zanubrutinib 3selinexor 3ruxolitinib 3revumenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Therapeutics × Other hematologic neoplasm × Clear all
NCT07301424 2026-05-06

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

University of Alberta

Phase 2 Not yet recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07526597 2026-04-13

STOP-CLL-DCT

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
45 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07371533 2026-01-28

A-319

Shanxi Bethune Hospital

Phase NA Not yet recruiting
18 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡